Since then though Peace the landscape has changed considerably. We have had Kynamro approval validate antisense technology, there has been continued clinical success with a range of antisense compounds and most importantly in the last few years just about all the major pharma have signed deals to get their hands on the technology.
On top of this the oral ms treatments have not had the impact, as previously predicted, on the market due to the lack of potency.
Since then though Peace the landscape has changed considerably....
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6865 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.8¢ | 141632 | 3 |
View Market Depth
| Last trade - 10.29am 25/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable